Boxer Capital’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Boxer Capital’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,400,000	Closed	-$27.3M	–	93
2021 Q3	$27.3M	Hold	2,400,000	–	–	0.95%	30
2021 Q2	$43.1M	Hold	2,400,000	–	–	1.52%	15
2021 Q1	$37.2M	Hold	2,400,000	–	–	1.26%	25
2020 Q4	$29.3M	Hold	2,400,000	–	–	0.94%	30
2020 Q3	$30.8M	Hold	2,400,000	–	–	1.07%	26
2020 Q2	$24.4M	Buy	2,400,000 +1,200,000	+100%	+$11M	1.07%	31
2020 Q1	$9.74M	Hold	1,200,000	–	–	0.67%	37
2019 Q4	$10.4M	Buy	+1,200,000	New	+$6.73M	0.59%	39

Other funds holding MRNS

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return

683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return